skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Update on the management of constipation in the elderly: new treatment options

Review

(5268) Views  (2056) Full article downloads

Authors: Satish SC Rao, Jorge T Go

Published Date June 2010 Volume 2010:5 Pages 163 - 171
DOI: http://dx.doi.org/10.2147/CIA.S8100

Satish SC Rao, Jorge T Go

Section of Neurogastroenterology, Division of Gastroenterology-Hepatology, Department of Internal Medicine, Iowa City, University of Iowa Carver College of Medicine, Iowa City, Iowa

Abstract: Constipation disproportionately affects older adults, with a prevalences of 50% in community-dwelling elderly and 74% in nursing-home residents. Loss of mobility, medications, underlying diseases, impaired anorectal sensation, and ignoring calls to defecate are as important as dyssynergic defecation or irritable bowel syndrome in causing constipation. Detailed medical history on medications and co-morbid problems, and meticulous digital rectal examination may help identify causes of constipation. Likewise, blood tests and colonoscopy may identify organic causes such as colon cancer. Physiological tests such as colonic transit study with radio-opaque markers or wireless motility capsule, anorectal manometry, and balloon expulsion tests can identify disorders of colonic and anorectal function. However, in the elderly, there is usually more than one mechanism, requiring an individualized but multifactorial treatment approach. The management of constipation continues to evolve. Although osmotic laxatives such as polyethylene glycol remain mainstay, several new agents that target different mechanisms appear promising such as chloride-channel activator (lubiprostone), guanylate cyclase agonist (linaclotide), 5HT4 agonist (prucalopride), and peripherally acting μ-opioid receptor antagonists (alvimopan and methylnaltrexone) for opioid-induced constipation. Biofeedback therapy is efficacious for treating dyssynergic defecation and fecal impaction with soiling. However, data on efficacy and safety of drugs in elderly are limited and urgently needed.

Keywords: constipation, elderly, treatment








Readers of this article also read:

Lubiprostone: a novel treatment for chronic constipation
Use of anticoagulants in elderly patients: practical recommendations
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
Assessment and management of nutrition in older people and its importance to health
Risk of “silent stroke” in patients older than 60 years: risk assessment and clinical perspectives
Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
Clinical intervention in aging: ethicolegal issues in assessing risk and benefit
Comment: update on the management of constipation in the elderly: new treatment options
Iatrogenic disease in the elderly: risk factors, consequences, and prevention
Correcting magnesium deficiencies may prolong life